Scivision Biotech Inc. (1786)
Market Closed
15 Jun, 05:30
TWSE TWSE Primary NT$
56. 00
-0.4
-0.7092%
NT$
5.91B Market Cap
15.55 P/E Ratio
- Div Yield
204,809 Volume
5.99 Eps
NT$ 56.4
Previous Close Want to track 1786 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Scivision Biotech Inc. (1786) Statistics
Valuation metrics
Market Cap 5.91B
Enterprise value 3.79B
Trailing P/E (ttm) 33.12
Forward P/E -
PEG ratio -0.65
Price/Sales (ttm) 4.75
Price/Book (mrq) 2.27
Enterprise Value/Revenue 4.27
Enterprise Value/EBITDA 19.13
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 517.43K
Average volume (90 days) 393.85K
Price summary
52-Week low 51.3
52-Week high 124
Beta -
50-Day moving average 56.69
200-Day moving average 68.01
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate 1.91
Trailing annual dividend yield 0.0338%
5-Year annual dividend yield -
Payout ratio 1.84
Dividend Date 29 May 2026
Ex-Dividend Date 29 Apr 2026
Last split factor 1,085:1,000
Last split Date 4 Oct 2021
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin 0.14%
Operating margin 0.17%
Operational effectiveness
Return on assets 0.05%
Return on equity 0.07%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 11.86
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 1.7
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 14.6
Total debt (mrq) -
Total Debt/Equity (mrq) 0.26
Current ratio (mrq) 4.09%
Book value per share (mrq) 24.85
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
